DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Leustatin (Cladribine) - Current Clinical Trials

 
 



Leustatin Related Clinical Trials

Allogeneic Transplantation Using Timed Sequential Busulfan, Cladribine, and Fludarabine Conditioning in Patients With Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) [Recruiting]

Cladribine Plus Idarubicin Plus Cytarabine (ARAC) in Patients With Acute Myeloid Leukemia (AML), High Risk Myelodysplastic Syndrome (HR MDS) or Myeloid Blast Phase of Chronic Myeloid Leukemia (CML) [Recruiting]

Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS) [Recruiting]

2CDA With Rituximab in Hairy Cell Leukemia [Recruiting]

Treatment of Macroglobulinemic Lymphoma With 2CdA, Cyclophosphamide and Rituximab [Active, not recruiting]

2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES) [Completed]

4-Arm Phase II Study of SGI-110 in Elderly Acute Myeloid Leukemia (AML) [Recruiting]

R-2cda and Prolongation of Therapy With Rituximab Alone in Chronic Lymphocytic Leukaemia and Small Lymphocytic Lymphoma [Recruiting]

Bortezomib, Cladribine, and Rituximab in Treating Patients With Advanced Mantle Cell Lymphoma or Indolent Lymphoma [Active, not recruiting]

Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's Lymphoma [Active, not recruiting]

Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes [Recruiting]

Study Assessing the Interaction of Pantoprazole With Cladribine in Subjects With Multiple Sclerosis [Completed]

Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma (PSHCI 10-011) [Recruiting]

Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia [Recruiting]

Prospective Observational Long-term Safety Registry of Multiple Sclerosis Patients Who Have Participated in Cladribine Clinical Trials [Recruiting]

Oral Cladribine in Early Multiple Sclerosis (MS) [Completed]

Therapy Optimisation for the Treatment of Hairy Cell Leukemia [Recruiting]

Rituximab Plus 2CdA in Patients With Advanced or Relapsed Mucosa Associated Lymphoid Tissue (MALT) Lymphoma [Completed]

A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) [Completed]

Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia With Cladribine Plus Rituximab [Completed]

Cladribine Based Induction Therapy With All-Trans Retinoic Acid and Midostaurin in Relapsed/Refractory AML [Completed]

Evaluation of Efficacy and Tolerance of Cladribine in Symptomatic Pulmonary Langerhans Cell Histiocytosis [Recruiting]

Cladribine, Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML) [Recruiting]

Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma [Completed]

Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma [Active, not recruiting]

Cladribine in Patients With Mantle Cell Lymphoma [Completed]

CLARITY Extension Study [Completed]

Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis [Recruiting]

Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL [Completed]

Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia [Completed]

LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis [Recruiting]

Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia [Completed]

Study of CLAG + Selinexor in Relapsed or Refractory Acute Myeloid Leukemia [Recruiting]

Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [Completed]

Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia [Completed]

Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia [Completed]

Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia [Recruiting]

Phase II Pilot Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) for Early Stage Primary Sclerosing Cholangitis [Completed]

A Study of Maintenance Treatment With MabThera (Rituximab) in Patients With Progressive B-cell Chronic Lymphocytic Leukemia [Active, not recruiting]

Nonmyeloablative Allogeneic Transplant [Recruiting]

Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant Glioma [Completed]

Idarubicin Plus Cytarabine (IA) vs IA Plus Cladribine (IAC) as Induction Regimen to Treat Initially Diagnosed Acute Myeloid Leukemia (AML) [Not yet recruiting]

Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy [Completed]

Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents [Active, not recruiting]

Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations [Not yet recruiting]

Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL) [Recruiting]

A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia [Withdrawn]

BL22 Immunotoxin in Treating Patients Previously Treated With Cladribine for Hairy Cell Leukemia [Completed]

Treatment of Relapsed T-Cell Acute Lymphoblastic Leukemia or T-Lymphoblastic Lymphoma With MabCampath [Completed]

CLAG Gleevec in Relapsed or Refractory Acute Myeloid Leukemia (AML) [Completed]

Clofarabine in Chronic Lymphocytic Leukemia [Completed]

German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults [Completed]

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003) [Recruiting]

Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Completed]

Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia [Completed]

Unrelated Donor Stem Cell Transplantation [Recruiting]

Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma [Terminated]

Use of Tamoxifen in Systemic Mastocytosis [Recruiting]

Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML [Recruiting]

A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia [Completed]

Phase II Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis [Not yet recruiting]

Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia [Completed]

Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL) [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017